LicianPro

RNAC holders · CITADEL ADVISORS LLC 13F · RNAC stock

CITADEL ADVISORS LLC Cartesian Therapeutics Inc. (RNAC) 13F holding

CITADEL ADVISORS LLC reported 110,128 RNAC shares valued at $677.3K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest RNAC 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the RNAC holders table.

RNAC reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-31110,128$677.3KCOM NEW
2025-12-3179,785$575.3KCOM NEW
2025-09-3070,524$720.8KCOM NEW
2025-06-30120,874$1.3MCOM NEW

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.